Top Markets
#1 Akedo Akedo +60.74%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.99%
#4 Velvet Velvet +41.65%
#5 Black Phoenix Black Phoenix +34.54%
#6 τemplar τemplar +27.45%
#7 Ribbita by Virtuals Ribbita by Virtuals +18.82%
#8 Bitway Bitway +17.84%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.42%
#10 Cap Cap +15.27%
Coin of the day
Akedo Akedo
설정
언어
한국어
통화
USD
테마
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
주식 순위 #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
주가
$0.08765138
마지막 동기화: 2025-12-23
시가총액
$1.11M
변동 (1일)
0.45%
변동 (1년)
-28.78%
국가
CA
거래 Psyence Group Inc. (PSYG)

카테고리

Healthcare
Psyence Group Inc. (PSYG)의 주가 이력
최고 종가: $0.09 (2025-12-01 기준)

최저 종가: $0.17 (2021-01-01 기준)
Psyence Group Inc.의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 10.84%
2025 -20.78%
2024 -39.49%
2023 111.53%
2022 -39.61%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.18K 72.71%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $260.38 49.03%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $249.16 21.73%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $470.54 44.82%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $135.64 63.90%
US